Oncol Rep. 2022 Dec;48(6):212. doi: 10.3892/or.2022.8427. Epub 2022 Oct 20.
PMID:36263622
Uterine epithelioid smooth muscle tumor of uncertain malignant potential.
Gomez NF, Zhao J, Smith B.
Int J Gynecol Cancer. 2023 Aug 7;33(8):1324-1325. doi: 10.1136/ijgc-2022-004117.
PMID:37268311
Malignant potential of endometrial stromal tumor with limited infiltration: a case report.
Su TF, Chao TK, Lee HS, Perng CL, Nieh S.
Int J Surg Pathol. 2014 Sep;22(6):559-63. doi: 10.1177/1066896913506934. Epub 2013 Oct 23.
PMID:24155223
Effects of morcellation of uterine smooth muscle tumor of uncertain malignant potential and endometrial stromal sarcoma: case series and recommendations for clinical practice.
EphA2- and HDAC-Targeted Combination Therapy in Endometrial Cancer.
Joseph R, Dasari SK, Umamaheswaran S, Mangala LS, Bayraktar E, Rodriguez-Aguayo C, Wu Y, Nguyen N, Powell RT, Sobieski M, Liu Y, Kim MS, Corvigno S, Foster K, Hanjra P, Vu TC, Chowdhury MA, Amero P, Stephan C, Lopez-Berestein G, Westin SN, Sood AK.
Int J Mol Sci. 2024 Jan 20;25(2):1278. doi: 10.3390/ijms25021278.